COSMA Dementia App entry into Scandinavian Market

随着年龄的增长，全球人口中有记忆问题、抑郁、时空迷失或逻辑推理能力下降的比例越来越高。这些出现的症状可能导致早期神经退行性疾病，如痴呆症。随着这些情况的进展，脑电波活动减少。现有的药物治疗具有严重的副作用，而非药物治疗即大脑训练应用程序不是针对患者的，也没有经过临床试验验证。我们旨在通过开发一种独特的个性化、临床验证的认知应用程序来解决这个全球问题，该应用程序通过应用治疗性游戏和机器学习来改善患者的认知大脑功能。好处：(1)非侵入性；(2)改善智力；(3)全球市场；(5)确保患者独立；(6)减轻医疗保健系统的压力；以及(6)将加强英国在神经疾病研究方面的领先地位。

There is an increasing proportion of the global population with memory problems, depression, space-time disorientation or decreased logical reasoning with aging. These onset symptoms may lead to early-stage neurodegenerative disorders e.g. dementia. As these conditions progress, the brainwave activities decline.Present drug treatments come with severe side-effects, and non-drug treatments i.e. brain training apps are not patient specific and are not validated through clinical trials.We aim to address this global issue by developing a unique-personalised, clinically validated cognitive app which improves a patient's cognitive brain function through application of therapeutic games and machine learning.Benefits: (1) non-invasive; (2) improved mental ability; (3) global market; (5) ensures patient independence; (6) reduced stress upon healthcare systems; and (6) will strengthen UK as leader in neurological disorder research.